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1 PHARMACEUTICAL SERVICE 
CONSTITUTES PART OF SOCIAL 





































1  Directive 2001/83/EC of the European Parliament and of the Council 










Administration and supervision of the social welfare and healthcare 
services 
The	Ministry	 of	 Social	 Affairs	 and	Health	 is	 responsible	 for	 the	
administrative	 development	 of	 the	 pharmaceutical	 service,	 the	




















3  Medicines Act 395/1987
4  Act on Health Care Professionals (559/1994)
5  Health Insurance Act 1224/2004
6  Act on the Status and Rights of Patients 785/1992
7  Act on the Status and Rights of Social Welfare Clients 812/2000
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2 PHARMACEUTICAL SERVICE IS OF 
HIGH QUALITY, EFFICIENT AND COST-
EFFECTIVE
2.1 ENSURE ACCESS TO MEDICINES AND 































































	 ensured	 competitive	 conditions	 will	maintain	 a	 well-functioning	
pharmaceutical	service
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2.2 FINANCING SYSTEMS PROMOTE 
MATERIALISATION OF ECONOMICALLY MOST 
ADVANTAGEOUS PHARMACOTHERAPIES AND 



































8  Expert group of the National Institute for Health and Welfare: Sosiaali- ja terveydenhuollon monikanavaisen 















2.3 MEDICINE REIMBURSEMENT SYSTEM IS 






































































3 RATIONAL PHARMACOTHERAPY 
AND GOOD MEDICATION SAFETY 
IMPROVE PEOPLE’S WELLBEING 
AND PUBLIC HEALTH, DECREASING 
HEALTHCARE EXPENDITURE
3.1 MEDICINE USERS ARE ENCOURAGED TO ASSUME 
RESPONSIBILITY FOR TREATMENT OF THEIR 
DISEASES



















































3.2 INCREASE PRODUCTION OF RELIABLE 
INFORMATION ON RATIONAL 
PHARMACOTHERAPIES DISSEMINATED TO 
HEALTHCARE PROFESSIONALS AND MEDICINE 
USERS



















































































3.3 PROMOTE EFFICIENT, SAFE, RATIONAL AND 






















































































































4 PHARMACEUTICAL RESEARCH 
IMPROVES HEALTH, WELLBEING AND 
EMPLOYMENT RATES
4.1 PROMOTE GENERATION AND EXPLOITATION 










































































4.2 PROMOTE RATIONAL PHARMACOTHERAPIES 
THROUGH EVALUATIONS OF THERAPEUTIC 












































































	 increased	 information	on	medicine	use	helps	 to	 identify	 the	areas	
requiring	new	resources
31
5 VETERINARY SERVICE SAFEGUARDS 
PUBLIC HEALTH AND PROMOTES 
WELLBEING OF HUMANS AND 
ANIMALS











































































































6 FOLLOW-UP PLAN FOCUSING ON 
IMPLEMENTATION OF PROPOSED 



















































Healthcare expenditure in 1995-2008 at 2008 prices, in millions euro 
Gross investments in healthcare
Travelling  
Administrative expenses of 
healthcare  
Equipment and other medicinal 
durables  
 
Medicines and other medicinal 
consumables  
 
Other healthcare  




Inpatient care of older persons
 Occupational and student 
healthcare  
Dental healthcare  
Primary healthcare (excluding 
occupational, student and dental 
healthcare)
Specialised medical care
















































































































































































































































































































































































































































































Organisations involved in the preparation of the Medicines Policy 2020
Ministry	of	Social	Affairs	and	Health	Finnish	Medicines	Agency	Fimea
National	Supervisory	Authority	for	Welfare	and	Health	Valvira













































Definitions used in the Medicines Policy 2020 document 








































3) Rational pharmacotherapy, monitoring of drug treatment, comprehensive 




Monitoring of drug treatment 
Part	of	the	medication	process,	see	medication	process.	













Comprehensive medication assessment, comprehensive medication review 











4) Integrated care pathway, individual treatment pathway, pharmacotherapy 
process, unit-based and individual pharmacotherapy plan, interprofessional 
collaboration and ward pharmacy 




and	 their	particular	 symptoms.	Based	on	 the	agreements	between	 the	
organisations	on	the	arrangement	of	the	treatment	of	a	particular	disease	
(Source:	Norback	et	al.	2010)	






































Ward	pharmacy	 is	 the	pharmaceutical	 service	work	performed	by	 the	
pharmaceutical	staff	at	the	wards	(Fimea	administrative	regulation	7/2007).	
5) Customer-orientation, treatment adherence, concordance, self-
management, self-care
Customer oriented services, patient oriented services



























6) Efficacy, effectiveness, cost-effectiveness (efficiency) and incremental cost-
































8) Pharmaceutical information 
Pharmaceutical (drug/medicines) information 
Information	about	medicines	and	pharmacotherapies,	available	to	consumers	
and	healthcare	professionals	through	various	information	channels,	either	face-
to-face	or	through	written	or	electronic	services	(telephone,	Internet,	TV	and	
radio).	Pharmaceutical	information	is	produced	by	the	authorities,	healthcare	
professionals,	the	pharmaceutical	industry	and	patient	organisations.	The	basis	
of	medicine-specific	information	is	the	summary	of	product	characteristics,	
SPC)	adopted	together	with	the	marketing	authorisation,	as	well	as	the	
package	leaflet	based	on	it.	(Sources:	Directive	2001/83/EC,	Pohjanoksa-
Mäntylä	2010,	Salonen	2010).
Patient/medication counselling 
A	discussion	between	the	client/patient	and	the	healthcare	professional	
where	the	professional,	taking	the	client’s	personal	needs	and	situation	into	
consideration,	supports	his	or	her	coping	with	the	pharmacotherapy	(Sources:	
USP	1997,	Hakkarainen	and	Airaksinen	2001)	
9) Veterinary service
Animal	healthcare	and	treatment	of	animal	diseases	as	well	as	other	veterinary	
assistance,	meat	and	milk	inspection,	health-related	control	and	inspection	
of	the	production	of	animal-based	foodstuffs	and	animal	husbandry,	fighting	
and	prevention	of	veterinary	diseases	as	well	as	animal	protection	(Veterinary	
Service	Act	685/1990).	
